VXRT - These 2 Stocks Carry a Lot of Risk but Their Upside Is Huge
2023-04-24 05:30:00 ET
Some companies offer you plenty of earnings visibility -- even if their shares slip in the near term, you're pretty confident they'll gain over time. You'll want a lot of these stocks in your portfolio. But if you're comfortable with risk, you may want to add another sort of player to the mix: innovative companies that have hit some roadblocks, but may have a shot at success.
Right now, Novavax (NASDAQ: NVAX) and Vaxart (NASDAQ: VXRT) are in this situation. Both were favorites in the early days of the coronavirus vaccine race. Today, though, they've had to cut costs and shift strategies after falling behind. These two stocks carry a great deal of risk, but their upside could be tremendous. Let's check them out.
Novavax shares soared more than 2,700% back in 2020. The government invested in the development of the company's coronavirus vaccine candidate -- and investors bet on it quickly entering the vaccine market. But the program fell behind and Novavax won authorization more than a year after leaders Pfizer and Moderna . That meant it missed out on the biggest opportunity for vaccine revenue.
For further details see:
These 2 Stocks Carry a Lot of Risk, but Their Upside Is Huge